Merck & Co Inc logo

MRK - Merck & Co Inc Share Price

$82.26 0.7  0.9%

Last Trade - 05/06/20

Large Cap
Market Cap £163.97bn
Enterprise Value £180.28bn
Revenue £37.97bn
Position in Universe 32nd / 6325
Unlock MRK Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Merck & Co., Inc. revenues increased 11% to $12.06B. Net income before extraordinary items increased 8% to $3.22B. Revenues reflect Merck Pharmaceutical segment increase from $10.69B to $22.52B, Unallocated segment increase of 85% to $165M, United States segment increase of 14% to $5.14B, Europe, Middle East and Africa segment increase of 14% to $3.53B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


MRK Revenue Unlock MRK Revenue

Net Income

MRK Net Income Unlock MRK Revenue

Normalised EPS

MRK Normalised EPS Unlock MRK Revenue

PE Ratio Range

MRK PE Ratio Range Unlock MRK Revenue

Dividend Yield Range

MRK Dividend Yield Range Unlock MRK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MRK EPS Forecasts Unlock MRK Revenue
Profile Summary

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated July 28, 1970
Public Since June 15, 1946
No. of Shareholders: 109,500
No. of Employees: 71,000
Sector Healthcare
Industry Pharmaceuticals
Index Dow Jones Composite , Dow Jones Industrial Average , FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 2,524,101,191
Free Float (0.0%)
Eligible for
MRK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MRK
Upcoming Events for MRK
Monday 8th June, 2020
Merck & Co Inc at Biotechnology Industry Organization (BIO) International Convention (Virtual)
Friday 12th June, 2020
Dividend For MRCK34.SA - 3.2757 BRL
Friday 12th June, 2020
Dividend For MRK.N - 0.6100 USD
Friday 31st July, 2020
Q2 2020 Merck & Co Inc Earnings Call
Friday 31st July, 2020
Q2 2020 Merck & Co Inc Earnings Release
Tuesday 27th October, 2020
Q3 2020 Merck & Co Inc Earnings Call
Tuesday 27th October, 2020
Q3 2020 Merck & Co Inc Earnings Release
Frequently Asked Questions for Merck & Co Inc
What is the Merck & Co Inc share price?

As of 05/06/20, shares in Merck & Co Inc are trading at $82.26, giving the company a market capitalisation of £163.97bn. This share price information is delayed by 15 minutes.

How has the Merck & Co Inc share price performed this year?

Shares in Merck & Co Inc are currently trading at $82.26 and the price has moved by 1.01% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Merck & Co Inc price has moved by -6.75% over the past year.

What are the analyst and broker recommendations for Merck & Co Inc?

Of the analysts with advisory recommendations for Merck & Co Inc, there are there are currently 6 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Merck & Co Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Merck & Co Inc next release its financial results?

Merck & Co Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Merck & Co Inc dividend yield?

The Merck & Co Inc dividend yield is 2.82% based on the trailing twelve month period.

Does Merck & Co Inc pay a dividend?

Last year, Merck & Co Inc paid a total dividend of 2.32, and it currently has a trailing dividend yield of 2.82%. Looking ahead, shares in Merck & Co Inc are due to go ex-dividend on 2020-06-12 and the next dividend pay date is 2020-07-07.

When does Merck & Co Inc next pay dividends?

Merck & Co Inc are due to go ex-dividend on 2020-06-12 and the next dividend pay date is 2020-07-07. The historic dividend yield on Merck & Co Inc shares is currently 2.82%.

How do I buy Merck & Co Inc shares?

To buy shares in Merck & Co Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Merck & Co Inc?

Shares in Merck & Co Inc are currently trading at $82.26, giving the company a market capitalisation of £163.97bn.

Where are Merck & Co Inc shares listed? Where are Merck & Co Inc shares listed?

Here are the trading details for Merck & Co Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: MRK
What kind of share is Merck & Co Inc?

Based on an overall assessment of its quality, value and momentum, Merck & Co Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Merck & Co Inc share price forecast 2020?

Shares in Merck & Co Inc are currently priced at $82.26. At that level they are trading at 7.06% discount to the analyst consensus target price of 0.00.

Analysts covering Merck & Co Inc currently have a consensus Earnings Per Share (EPS) forecast of 5.315 for the next financial year.

How can I tell whether the Merck & Co Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Merck & Co Inc. Over the past six months, the relative strength of its shares against the market has been -6.71%. At the current price of $82.26, shares in Merck & Co Inc are trading at -1.11% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Merck & Co Inc PE Ratio?

The Merck & Co Inc PE ratio based on its reported earnings over the past 12 months is 15.1. The shares are currently trading at $82.26.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Merck & Co Inc?

Merck & Co Inc's management team is headed by:

Robert Davis - CFO
Kenneth Frazier - CHM
Steven Mizell - CHO
Franklin Clyburn - EVP
Michael Nally - EVP
Sanat Chattopadhyay - EVP
Jennifer Zachary - EVP
Leslie Brun - LED
Julie Gerberding - EVP
Thomas Glocer - IND
Thomas Cech - IND
Richard DeLuca - EVP
Mary Coe - IND
Pamela Craig - IND
Roger Perlmutter - EVP
Who are the major shareholders of Merck & Co Inc?

Here are the top five shareholders of Merck & Co Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.6% (217.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.18% (130.7m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.65% (117.3m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.96% (74.7m shares)
Vanguard 500 Index Fund Mutual Fund
Percentage owned: 2.06% (52.1m shares)
Similar to MRK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.